company background image
COV logo

Covalon Technologies TSXV:COV Stock Report

Last Price

CA$1.09

Market Cap

CA$26.9m

7D

-0.9%

1Y

-45.5%

Updated

23 Apr, 2024

Data

Company Financials

Covalon Technologies Ltd.

TSXV:COV Stock Report

Market Cap: CA$26.9m

COV Stock Overview

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.

COV fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Covalon Technologies Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Covalon Technologies
Historical stock prices
Current Share PriceCA$1.09
52 Week HighCA$2.14
52 Week LowCA$0.96
Beta0.53
1 Month Change-14.84%
3 Month Change1.87%
1 Year Change-45.50%
3 Year Change-24.83%
5 Year Change-78.63%
Change since IPO-63.67%

Recent News & Updates

Covalon Technologies Ltd.'s (CVE:COV) Price Is Right But Growth Is Lacking After Shares Rocket 25%

Feb 17
Covalon Technologies Ltd.'s (CVE:COV) Price Is Right But Growth Is Lacking After Shares Rocket 25%

Insufficient Growth At Covalon Technologies Ltd. (CVE:COV) Hampers Share Price

Dec 22
Insufficient Growth At Covalon Technologies Ltd. (CVE:COV) Hampers Share Price

Recent updates

Covalon Technologies Ltd.'s (CVE:COV) Price Is Right But Growth Is Lacking After Shares Rocket 25%

Feb 17
Covalon Technologies Ltd.'s (CVE:COV) Price Is Right But Growth Is Lacking After Shares Rocket 25%

Insufficient Growth At Covalon Technologies Ltd. (CVE:COV) Hampers Share Price

Dec 22
Insufficient Growth At Covalon Technologies Ltd. (CVE:COV) Hampers Share Price

We Think Covalon Technologies (CVE:COV) Can Afford To Drive Business Growth

Sep 02
We Think Covalon Technologies (CVE:COV) Can Afford To Drive Business Growth

We Think Covalon Technologies (CVE:COV) Needs To Drive Business Growth Carefully

May 26
We Think Covalon Technologies (CVE:COV) Needs To Drive Business Growth Carefully

Is Covalon Technologies (CVE:COV) Using Too Much Debt?

Apr 29
Is Covalon Technologies (CVE:COV) Using Too Much Debt?

Covalon Technologies (CVE:COV) Is Making Moderate Use Of Debt

Dec 29
Covalon Technologies (CVE:COV) Is Making Moderate Use Of Debt

Shareholder Returns

COVCA BiotechsCA Market
7D-0.9%-5.8%-0.6%
1Y-45.5%-37.3%3.9%

Return vs Industry: COV underperformed the Canadian Biotechs industry which returned -37.3% over the past year.

Return vs Market: COV underperformed the Canadian Market which returned 3.9% over the past year.

Price Volatility

Is COV's price volatile compared to industry and market?
COV volatility
COV Average Weekly Movement14.2%
Biotechs Industry Average Movement13.6%
Market Average Movement9.1%
10% most volatile stocks in CA Market18.3%
10% least volatile stocks in CA Market3.1%

Stable Share Price: COV's share price has been volatile over the past 3 months.

Volatility Over Time: COV's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of Canadian stocks.

About the Company

FoundedEmployeesCEOWebsite
n/an/aBrent Ashtonwww.covalon.com

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company’s platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity. It also offers medical coating platform, a process that utilizes photo-polymerization to create active grafting sites where new polymer chains are initiated and propagated from the surface of an existing medical device.

Covalon Technologies Ltd. Fundamentals Summary

How do Covalon Technologies's earnings and revenue compare to its market cap?
COV fundamental statistics
Market capCA$26.89m
Earnings (TTM)-CA$4.93m
Revenue (TTM)CA$25.07m

1.1x

P/S Ratio

-5.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
COV income statement (TTM)
RevenueCA$25.07m
Cost of RevenueCA$11.56m
Gross ProfitCA$13.52m
Other ExpensesCA$18.45m
Earnings-CA$4.93m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.20
Gross Margin53.90%
Net Profit Margin-19.67%
Debt/Equity Ratio0%

How did COV perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.